News Sumitomo Dainippon Pharma Oncology Announces First Patient Dosed in Phase 1/2 Study of TP-0184 for the Treatment of Anemia in Patients with Low or Intermediate Risk Myelodysplastic Syndromes Sep 28, 2021 Posted by Sumitomo Pharma Oncology, Inc.
News David Dykeman Featured on Product Success Podcast: Quality and Medical Devices Sep 28, 2021 Posted by Greenberg Traurig, LLP
News Three Veterans of FDA’s Office of Chief Counsel, Jim Johnson, Scott Kaplan, and Chris Fanelli Join Sidley’s Global Healthcare and FDA Practice Sep 28, 2021
News National Institutes of Health awards SBIR contract to Kephera Diagnostics to develop a test-of-cure for Chagas disease Sep 23, 2021 Posted by Kephera Diagnostics
News eClinical Solutions to Spotlight Technology-Enabled Digital Transformation Strategies at 2021 Industry Conferences Sep 21, 2021
News SalioGen Therapeutics Strengthens Management with Key Additions to Leadership Team to Advance Its Gene Coding Platform Sep 16, 2021
News Astrocyte Pharmaceuticals Awarded Major Grant to Further Develop Promising Treatment for Brain Injury Sep 16, 2021
